The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska ...
Red blood is the exception, not the rule. Evolution has painted it green, purple and white in animals that push physiology ...
News-Medical.Net on MSN
Long-term diabetes changes red blood cells, increasing cardiovascular disease risk
The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
Thalassemia is a genetic blood disorder affecting thousands of children in India each year. Learn how early screening, timely ...
Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...
USFDA has cleared the world’s first oral therapy for the condition, a development that health experts say could transform ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
The US FDA has approved the drug Mitapivat, marketed as Aqvesme, as the very first oral therapy for anemia in adults with ...
Agios Pharma's shares soar 16% after FDA expands approval for its blood disorder drug, Aqvesme, set for late next month.
In a landmark advance for thalassemia care, US FDA has approved Mitapivat, the first oral treatment for anaemia in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback